PSMD1 and hematologic disorder: In SARS-CoV-2 susceptible individuals, Fahrner et al. (67) observed a specific deficit in the TH1/Tc1 response against the receptor binding domain of the spike protein (S1-RBD), and vaccine-induced S1-RBD TH1 immunity is reduced in hematological malignancies.